European Journal of Obstetrics & Gynecology and Reproductive Biology
Operator experience reduces the risk of second trimester amniocentesis-related adverse outcomes
Introduction
Mid-trimester amniocentesis remains the most common invasive procedure for prenatal diagnosis of chromosomal abnormalities, followed by chorionic villus sampling. Initially, the amniocentesis procedure was associated with a high risk of fetal loss, up to 1% [1], [2], [3], [4]. Nowadays new techniques, higher resolution ultrasound devices and more experienced operators have rendered amniocentesis a less precarious invasive method for prenatal diagnosis [5], [6].
In the 2001 American College of Obstetricians and Gynecologists (ACOG) guidelines, the fetal loss rate attributed to mid-trimester amniocentesis was described as one in every 200 procedures, whereas the same rate in 2007 was evaluated as almost one in 500 cases in singleton pregnancies [5], [6]. At the same time, a comparison of 3096 unselected women undergoing amniocentesis with 31,907 control women who did not, during the First and Second Trimester Evaluation of Risk (FASTER) Trial, showed that the amniocentesis-related fetal loss rate was only 0.06% (1/1600) [7]. Subsequent studies also reported low rates of miscarriage (0.16% and 0.13%) [8], [9].
Operator experience seems to be the most important factor affecting not only the risk of fetal loss but also of other adverse outcomes such as haemorrhagic fluid aspiration and the need for repeated puncture. It has been repeatedly shown that the learning curve for performing amniocentesis is significantly associated with procedure-related outcomes, as higher miscarriage and complication rates are recorded when amniocentesis is performed by less experienced physicians [10], [11], [12], [13], [14], [15]. Therefore, although competence is difficult to evaluate, performance quality should be monitored, adverse outcomes should be audited and a minimum number of invasive procedures per year must be also established [16], [17].
The aim of the present study was to investigate whether operator experience may have an actual impact on the risk of amniocentesis-related adverse outcomes.
Section snippets
Materials and methods
The records of all women with singleton pregnancies, who underwent mid-trimester amniocentesis performed between the 18th and 21st gestational weeks by the same operator for cytogenetic analysis in a single institution located in Northern Greece, during the period from January 1994 to December 2007, were reviewed. This is a private fetal medicine centre where more than 400 amniocenteses and 2000 scans are performed per year. The Institutional Review Board approved the present study. Informed
Results
In total, 5913 amniocenteses were performed during the whole period of our study. The annual number of procedures varied between 273 (in 1994) and 638 (in 2007) amniocenteses. The mean maternal age of women undergoing amniocentesis was 34.4 ± 5.1 years and mean gestational week at amniocentesis was 18.7 ± 1.8 weeks. Advanced maternal age (≥35 years old) and abnormal serum markers were the most common indications for amniocentesis throughout this period (52.3% and 22.8% respectively). Placental
Comment
Our analysis showed that the total adverse outcome rate (Fig. 1), as well as the hemorrhagic fluid aspiration, need for repeated puncture, insufficient fluid aspiration and dark fluid aspiration rates, separately (Fig. 2) were significantly reduced over the whole period of study. This reduction is indicative of the fact that the accumulation of operator's experience has a significant impact on such an invasive procedure.
In the ACOG practice bulletin of 2007, it is argued that incidence of
References (18)
- et al.
Randomised controlled trial of genetic amniocentesis in 4606 low-risk women
Lancet
(1986) - et al.
Operator experience and sample quality in genetic amniocentesis
Am J Obstet Gynecol
(2006) Midtrimester amniocentesis for prenatal diagnosis: safety and accuracy
J Am Med Assoc
(1976)- et al.
Prenatal genetic diagnosis in 3000 amniocenteses
N Engl J Med
(1979) Randomized trial to assess the safety and fetal outcomes of early and midtrimester amniocentesis
Lancet
(1998)Clinical management guidelines for obstetrician-gynecologists. Prenatal diagnosis of fetal chromosomal abnormalities. ACOG Practice Bulletin 27
Obstet Gynecol
(2001)Invasive prenatal testing for aneuploides. ACOG Practice Bulletin 88
Obstet Gynecol
(2007)- et al.
(FASTER) Trial Research Consortium. Pregnancy loss rates after mid-trimester amniocentesis
Obstet Gynecol
(2006) - et al.
Age-specific risk of fetal loss post second trimester amniocentesis: analysis of 5043 cases
Prenat Diagn
(2007)
Cited by (9)
In clinical care, volume matters
2016, American Journal of Obstetrics and GynecologyGenetic amniocentesis using atraumatic 29 gauge needle in patients having a chorioamniotic separation
2023, Journal of Perinatal MedicineComparison of pregnancy outcomes after second trimester amniocentesis between procedures performed by experts and non-experts
2021, Journal of Perinatal MedicinePopulation-based trends in prenatal screening and diagnosis for aneuploidy: A retrospective analysis of 38 years of state-wide data
2016, BJOG: An International Journal of Obstetrics and Gynaecology